Economic evaluations of childhood hearing loss screening programmes: A systematic review and critique

Rajan Sharma, Yuanyuan Gu, Teresa Y. C. Ching, Vivienne Marnane, Bonny Parkinson

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: Permanent childhood hearing loss is one of the most common birth conditions associated with speech and language delay. A hearing screening can result in early detection and intervention for hearing loss.

Objectives: To update and expand previous systematic reviews of economic evaluations of childhood hearing screening strategies, and explore the methodological differences.

Data Sources: MEDLINE, Embase, the Cochrane database, National Health Services Economic Evaluation Database (NHS EED), the Health Technology Assessment (HTA) database, and Canadian Agency for Drugs and Technologies in Health’s (CADTH) Grey matters.

Study Eligibility Criteria, Participants and Interventions: Economic evaluations reporting costs and outcomes for both the intervention and comparator arms related to childhood hearing screening strategies.

Results: Thirty evaluations (from 29 articles) were included for review. Several methodological issues were identified, including: few evaluations reported outcomes in terms of quality-adjusted life years (QALYs); none estimated utilities directly from surveying children; none included disutilities and costs associated with adverse events; few included costs and outcomes that differed by severity; few included long-term estimates; none considered acquired hearing loss; some did not present incremental results; and few conducted comprehensive univariate or probabilistic sensitivity analysis. Evaluations published post-2011 were more likely to report QALYs and disability-adjusted life years (DALYs) as outcome measures, include long-term treatment and productivity costs, and present incremental results.

Limitations: We were unable to access the economic models and, although we employed an extensive search strategy, potentially not all relevant economic evaluations were identified.

Conclusions and Implications: Most economic evaluations concluded that childhood hearing screening is value for money. However, there were significant methodological limitations with the evaluations.

LanguageEnglish
Pages331-357
Number of pages27
JournalApplied Health Economics and Health Policy
Volume17
Issue number3
Early online date25 Jan 2019
DOIs
Publication statusPublished - Jun 2019

Fingerprint

Hearing Loss
Cost-Benefit Analysis
Hearing
Quality-Adjusted Life Years
Language Development Disorders
Databases
Costs and Cost Analysis
Economic Models
Biomedical Technology Assessment
Biomedical Technology
Information Storage and Retrieval
Health Services Research
National Health Programs
MEDLINE
Health Care Costs
Outcome Assessment (Health Care)
Economic evaluation
Systematic review
Childhood
Screening

Keywords

  • economic evaluation
  • cost-effectiveness
  • cost-benefit
  • hearing loss
  • universal newborn hearing screening

Cite this

@article{e30f887519cc41ff8ae26923f8bfd509,
title = "Economic evaluations of childhood hearing loss screening programmes: A systematic review and critique",
abstract = "Background: Permanent childhood hearing loss is one of the most common birth conditions associated with speech and language delay. A hearing screening can result in early detection and intervention for hearing loss.Objectives: To update and expand previous systematic reviews of economic evaluations of childhood hearing screening strategies, and explore the methodological differences.Data Sources: MEDLINE, Embase, the Cochrane database, National Health Services Economic Evaluation Database (NHS EED), the Health Technology Assessment (HTA) database, and Canadian Agency for Drugs and Technologies in Health’s (CADTH) Grey matters.Study Eligibility Criteria, Participants and Interventions: Economic evaluations reporting costs and outcomes for both the intervention and comparator arms related to childhood hearing screening strategies.Results: Thirty evaluations (from 29 articles) were included for review. Several methodological issues were identified, including: few evaluations reported outcomes in terms of quality-adjusted life years (QALYs); none estimated utilities directly from surveying children; none included disutilities and costs associated with adverse events; few included costs and outcomes that differed by severity; few included long-term estimates; none considered acquired hearing loss; some did not present incremental results; and few conducted comprehensive univariate or probabilistic sensitivity analysis. Evaluations published post-2011 were more likely to report QALYs and disability-adjusted life years (DALYs) as outcome measures, include long-term treatment and productivity costs, and present incremental results.Limitations: We were unable to access the economic models and, although we employed an extensive search strategy, potentially not all relevant economic evaluations were identified.Conclusions and Implications: Most economic evaluations concluded that childhood hearing screening is value for money. However, there were significant methodological limitations with the evaluations.",
keywords = "economic evaluation, cost-effectiveness, cost-benefit, hearing loss, universal newborn hearing screening",
author = "Rajan Sharma and Yuanyuan Gu and Ching, {Teresa Y. C.} and Vivienne Marnane and Bonny Parkinson",
year = "2019",
month = "6",
doi = "10.1007/s40258-018-00456-1",
language = "English",
volume = "17",
pages = "331--357",
journal = "Applied Health Economics and Health Policy",
issn = "1175-5652",
publisher = "Adis International Ltd",
number = "3",

}

Economic evaluations of childhood hearing loss screening programmes : A systematic review and critique. / Sharma, Rajan; Gu, Yuanyuan; Ching, Teresa Y. C.; Marnane, Vivienne; Parkinson, Bonny.

In: Applied Health Economics and Health Policy, Vol. 17, No. 3, 06.2019, p. 331-357.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Economic evaluations of childhood hearing loss screening programmes

T2 - Applied Health Economics and Health Policy

AU - Sharma, Rajan

AU - Gu, Yuanyuan

AU - Ching, Teresa Y. C.

AU - Marnane, Vivienne

AU - Parkinson, Bonny

PY - 2019/6

Y1 - 2019/6

N2 - Background: Permanent childhood hearing loss is one of the most common birth conditions associated with speech and language delay. A hearing screening can result in early detection and intervention for hearing loss.Objectives: To update and expand previous systematic reviews of economic evaluations of childhood hearing screening strategies, and explore the methodological differences.Data Sources: MEDLINE, Embase, the Cochrane database, National Health Services Economic Evaluation Database (NHS EED), the Health Technology Assessment (HTA) database, and Canadian Agency for Drugs and Technologies in Health’s (CADTH) Grey matters.Study Eligibility Criteria, Participants and Interventions: Economic evaluations reporting costs and outcomes for both the intervention and comparator arms related to childhood hearing screening strategies.Results: Thirty evaluations (from 29 articles) were included for review. Several methodological issues were identified, including: few evaluations reported outcomes in terms of quality-adjusted life years (QALYs); none estimated utilities directly from surveying children; none included disutilities and costs associated with adverse events; few included costs and outcomes that differed by severity; few included long-term estimates; none considered acquired hearing loss; some did not present incremental results; and few conducted comprehensive univariate or probabilistic sensitivity analysis. Evaluations published post-2011 were more likely to report QALYs and disability-adjusted life years (DALYs) as outcome measures, include long-term treatment and productivity costs, and present incremental results.Limitations: We were unable to access the economic models and, although we employed an extensive search strategy, potentially not all relevant economic evaluations were identified.Conclusions and Implications: Most economic evaluations concluded that childhood hearing screening is value for money. However, there were significant methodological limitations with the evaluations.

AB - Background: Permanent childhood hearing loss is one of the most common birth conditions associated with speech and language delay. A hearing screening can result in early detection and intervention for hearing loss.Objectives: To update and expand previous systematic reviews of economic evaluations of childhood hearing screening strategies, and explore the methodological differences.Data Sources: MEDLINE, Embase, the Cochrane database, National Health Services Economic Evaluation Database (NHS EED), the Health Technology Assessment (HTA) database, and Canadian Agency for Drugs and Technologies in Health’s (CADTH) Grey matters.Study Eligibility Criteria, Participants and Interventions: Economic evaluations reporting costs and outcomes for both the intervention and comparator arms related to childhood hearing screening strategies.Results: Thirty evaluations (from 29 articles) were included for review. Several methodological issues were identified, including: few evaluations reported outcomes in terms of quality-adjusted life years (QALYs); none estimated utilities directly from surveying children; none included disutilities and costs associated with adverse events; few included costs and outcomes that differed by severity; few included long-term estimates; none considered acquired hearing loss; some did not present incremental results; and few conducted comprehensive univariate or probabilistic sensitivity analysis. Evaluations published post-2011 were more likely to report QALYs and disability-adjusted life years (DALYs) as outcome measures, include long-term treatment and productivity costs, and present incremental results.Limitations: We were unable to access the economic models and, although we employed an extensive search strategy, potentially not all relevant economic evaluations were identified.Conclusions and Implications: Most economic evaluations concluded that childhood hearing screening is value for money. However, there were significant methodological limitations with the evaluations.

KW - economic evaluation

KW - cost-effectiveness

KW - cost-benefit

KW - hearing loss

KW - universal newborn hearing screening

UR - http://www.scopus.com/inward/record.url?scp=85060604061&partnerID=8YFLogxK

U2 - 10.1007/s40258-018-00456-1

DO - 10.1007/s40258-018-00456-1

M3 - Article

VL - 17

SP - 331

EP - 357

JO - Applied Health Economics and Health Policy

JF - Applied Health Economics and Health Policy

SN - 1175-5652

IS - 3

ER -